Desmoplastic Small Round Cell Tumor (DSRCT) Clinical Trials in Guangzhou, Guangdong

Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.